Stanford researchers use AI to monitor rare cancer

Stanford researchers use AI to monitor rare cancer

After radiation therapy, certain cancer patients face a lingering question: Is a troubling lesion a return of the cancer, or is it damage caused by treatment? At Stanford, researchers are testing an artificial intelligence model designed to help doctors tell the difference. Dr. Michael Chang is an assistant professor in the department of otolaryngology at Stanford University School of Medicine, where he practices medicine as a specialized ear, n…